1-2 of 2
Markus Maulhardt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Idecabtagene Vicleucel (ide-cel) Shows Similar Efficacy and Toxicity in Patients with Multiple Myeloma Aged 70 and Older Compared to Younger Patients: A Multicenter Cohort Study

Philipp Berning, Markus Maulhardt, Hristo Boyadzhiev, Anca Maria Albici, Snjezana Janjetovic, Anna Ossami Saidy, Christian R Schultze-Florey, Simon Call, Natalie Schub, Annamaria Brioli, Michael Daskalakis, Juliane Knust, Justin Hasenkamp, Matthias Stelljes, Cyrus Khandanpour, Ulrike Bacher, Christine Hanoun, Florian Heidel, Hans Christian Reinhardt, Georg Lenz, Gerald Wulf, Friedrich Stölzel, Bastian von Tresckow, Thomas Pabst, Evgenii Shumilov
Journal: Blood
Blood (2024) 144 (Supplement 1): 3383.
https://doi.org/10.1182/blood-2024-198763
Published: 2024
Journal Articles

Efficacy of Idecabtagene Vicleucel (ide-cel) in Patients with Relapsed/Refractory Multiple Myeloma and Prior Central Nervous System Manifestation: A Retrospective Real-World Analysis

Markus Maulhardt, Philipp Berning, Christine Hanoun, Hristo Boyadzhiev, Anca Maria Albici, Snjezana Janjetovic, Anna Ossami Saidy, Simon Call, Natalie Schub, Enver Aydilek, Michael Daskalakis, Wolfram Jung, Justin Hasenkamp, Carolin Krekeler, Cyrus Khandanpour, Ulrike Bacher, Hans Christian Reinhardt, Georg Lenz, Friedrich Stölzel, Gerald Wulf, Thomas Pabst, Bastian von Tresckow, Evgenii Shumilov
Journal: Blood
Blood (2024) 144 (Supplement 1): 4759.
https://doi.org/10.1182/blood-2024-202467
Published: 2024